Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENA: Certican Regimens in De Novo Kidney Transplant
NCT01843348Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of everolimus in kidney transplantation, sponsored by Novartis. Started Dec 2012; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01843348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843348.